HUP9801691A2 - Havonta egy alkalommal beadandó injekció depo-fogamzásgátlóként valamint peri- és premenopauzális időszakban levő nők hormonhelyettesítő terápiájára - Google Patents
Havonta egy alkalommal beadandó injekció depo-fogamzásgátlóként valamint peri- és premenopauzális időszakban levő nők hormonhelyettesítő terápiájáraInfo
- Publication number
- HUP9801691A2 HUP9801691A2 HU9801691A HUP9801691A HUP9801691A2 HU P9801691 A2 HUP9801691 A2 HU P9801691A2 HU 9801691 A HU9801691 A HU 9801691A HU P9801691 A HUP9801691 A HU P9801691A HU P9801691 A2 HUP9801691 A2 HU P9801691A2
- Authority
- HU
- Hungary
- Prior art keywords
- replacement therapy
- injectable
- perimenopausal
- month
- useful
- Prior art date
Links
- 239000003433 contraceptive agent Substances 0.000 title 1
- 230000002254 contraceptive effect Effects 0.000 title 1
- 238000002657 hormone replacement therapy Methods 0.000 title 1
- 239000000262 estrogen Substances 0.000 abstract 3
- 229940011871 estrogen Drugs 0.000 abstract 3
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
- 230000002611 ovarian Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
- 238000009256 replacement therapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány havőnta egy alkalőmmal beadandó peri- és premenő-paűzálisidőszakban levő nők főgamzásgátlására és egyidejűleghőrmőnhelyettesítő terápiára alkalmas injekciós gyógyászati készítményelőállítására való alkalmazásra vőnatkőzik, amely hatóanyagkéntösztrögén és gesztagén kőmpőnenst tartalamaz. Ezzel a gyógyszerrelbiztőnságősabb főgamzásgátlás érhető el természetes ösztrőgénnel(etinil-ösztradiől nélkül), a kezdődő ösztrő-géncsökkenéskövetkeztében fellépő jelenségek hatásősan kezelhetők, valamint azőszteőpőrózis megelőzhető. ŕ
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19510861A DE19510861A1 (de) | 1995-03-16 | 1995-03-16 | Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9801691A2 true HUP9801691A2 (hu) | 1998-11-30 |
| HUP9801691A3 HUP9801691A3 (en) | 1999-03-01 |
Family
ID=7757668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9801691A HUP9801691A3 (en) | 1995-03-16 | 1996-03-15 | Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0814811A1 (hu) |
| JP (1) | JPH11501649A (hu) |
| KR (1) | KR19980703058A (hu) |
| AR (1) | AR002283A1 (hu) |
| AU (1) | AU713258B2 (hu) |
| CA (1) | CA2215382A1 (hu) |
| CZ (1) | CZ289697A3 (hu) |
| DE (1) | DE19510861A1 (hu) |
| HU (1) | HUP9801691A3 (hu) |
| IL (1) | IL117516A (hu) |
| MX (1) | MX9707009A (hu) |
| NO (1) | NO974255L (hu) |
| NZ (1) | NZ304027A (hu) |
| PL (1) | PL322202A1 (hu) |
| SK (1) | SK123997A3 (hu) |
| WO (1) | WO1996028165A1 (hu) |
| ZA (1) | ZA962177B (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
-
1995
- 1995-03-16 DE DE19510861A patent/DE19510861A1/de not_active Withdrawn
-
1996
- 1996-03-15 KR KR1019970706467A patent/KR19980703058A/ko not_active Application Discontinuation
- 1996-03-15 JP JP8527295A patent/JPH11501649A/ja not_active Ceased
- 1996-03-15 EP EP96907506A patent/EP0814811A1/de not_active Withdrawn
- 1996-03-15 AU AU51108/96A patent/AU713258B2/en not_active Ceased
- 1996-03-15 WO PCT/EP1996/001201 patent/WO1996028165A1/de not_active Application Discontinuation
- 1996-03-15 CA CA002215382A patent/CA2215382A1/en not_active Abandoned
- 1996-03-15 AR ARP960101766A patent/AR002283A1/es unknown
- 1996-03-15 CZ CZ972896A patent/CZ289697A3/cs unknown
- 1996-03-15 PL PL96322202A patent/PL322202A1/xx unknown
- 1996-03-15 MX MX9707009A patent/MX9707009A/es not_active IP Right Cessation
- 1996-03-15 HU HU9801691A patent/HUP9801691A3/hu unknown
- 1996-03-15 SK SK1239-97A patent/SK123997A3/sk unknown
- 1996-03-15 NZ NZ304027A patent/NZ304027A/xx not_active IP Right Cessation
- 1996-03-17 IL IL11751696A patent/IL117516A/xx not_active IP Right Cessation
- 1996-03-18 ZA ZA962177A patent/ZA962177B/xx unknown
-
1997
- 1997-09-15 NO NO974255A patent/NO974255L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ289697A3 (en) | 1997-12-17 |
| ZA962177B (en) | 1996-07-29 |
| HUP9801691A3 (en) | 1999-03-01 |
| MX9707009A (es) | 1997-11-29 |
| JPH11501649A (ja) | 1999-02-09 |
| AU713258B2 (en) | 1999-11-25 |
| NZ304027A (en) | 2000-05-26 |
| NO974255L (no) | 1997-11-14 |
| KR19980703058A (ko) | 1998-09-05 |
| PL322202A1 (en) | 1998-01-19 |
| EP0814811A1 (de) | 1998-01-07 |
| IL117516A (en) | 2000-07-26 |
| IL117516A0 (en) | 1996-07-23 |
| AR002283A1 (es) | 1998-03-11 |
| AU5110896A (en) | 1996-10-02 |
| DE19510861A1 (de) | 1996-09-19 |
| NO974255D0 (no) | 1997-09-15 |
| SK123997A3 (en) | 1998-02-04 |
| WO1996028165A1 (de) | 1996-09-19 |
| CA2215382A1 (en) | 1996-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2174920T3 (es) | Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno. | |
| DE69710896D1 (en) | Progestogen-anti-progestogen therapien | |
| BG101553A (en) | Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives | |
| HUP9901662A2 (hu) | Gesztagén és ösztrogén kombinációjából álló kit és eljárás nőnemű emlősök fogamzásának gátlására | |
| IL94416A (en) | Pharmaceutical compositions containing dihydrospirorenone | |
| DE3888269T2 (de) | Hormon-Zusammensetzung und -Anwendung. | |
| NO921854D0 (no) | Oral osmotisk doseringsform for fertilitetskontroll | |
| KR960700727A (ko) | 호르몬 대체 치료(hormone replacement therapy) | |
| ATE239483T1 (de) | Pharmazeutisches kombinationspräparat, kit und methode zur hormonalen kontrazeption | |
| DK0491443T3 (da) | Svangerskabsforebyggende middel med kun progestogen | |
| EP0663835A1 (en) | USE OF PARATHORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES FOR THE TREATMENT OF PREGNANCY PROBLEMS. | |
| WO1994002103A3 (de) | Ovulationshemmendes mittel zur hormonalen kontrazeption | |
| HUP9904508A2 (hu) | Egy ösztrogén vegyületet és egy progesztatív vegyületet tartalmazó hormonkészítmény | |
| HUP9801691A2 (hu) | Havonta egy alkalommal beadandó injekció depo-fogamzásgátlóként valamint peri- és premenopauzális időszakban levő nők hormonhelyettesítő terápiájára | |
| HUP9904345A2 (hu) | Orális fogamzásgátló | |
| MD970244A (en) | Dimer lysozime new application | |
| GR3025872T3 (en) | Orally active derivatives of 1,3,5(10)-estratriene | |
| HUP9904049A2 (hu) | Növekedési hormon komponens és csont antireszorpciós hatóanyag együttes felhasználása a csontritkulás ciklikus(koherens) kezelésében | |
| BR9906862A (pt) | Uso de uma quantidade eficaz de um agente desubstituição hormonal para o tratamento demenopausa humana e de endometriose | |
| UA41351C2 (uk) | Спосіб контрацепції та набір таблеток | |
| Webb | Gestagens, danazol and antiprogestogen in emergency contraception | |
| Fujii et al. | Follow-up Study of Intracapsular Femoral Neck Fracture in Aged Patients | |
| RS50389B (sr) | Upotreba antiprogestina za profilaksu i lečenje hormonskih zavisnih bolesti | |
| MX9707008A (es) | Uso de antiestrogenos para control natal en hombres. | |
| MY110528A (en) | Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses |